Strongest link seen for those with >20 pack-years

Some evidence seen for ESIs reducing pain and disability in cervical and lumbar radiculopathies and possibly in lumbar spinal stenosis

Progression-free survival significantly lower with fixed-duration acalabrutinib-venetoclax with or without obinutuzumab

Olpasiran leads to significant and sustained reduction in OxPL on apolipoprotein B

Lower risk for COPD exacerbations seen with SGLT-2 inhibitors and GLP-1 receptor agonists, but not with DPP-4 inhibitors

Although screening rates are higher for exposed individuals, rates are low in both exposed and unexposed individuals

National hospital occupancy of about 85 percent expected by 2032 for adult beds, by 2035 for adult and pediatric beds combined

Relative decline seen in cancer mortality among Blacks, but they still have higher mortality rates than Whites

Counties without gastroenterologists more likely to be nonmetropolitan, have older populations, have lower median household income

Almost all older adults in SPRINT trial have predicted net benefit favoring systolic BP target <120 mm Hg versus <140 mm Hg